Peptide questions · Tirzepatide
How long does tirzepatide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Tirzepatide’s onset is days–2 weeks, its peak effect comes at 72+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: SURMOUNT Phase III trials. FDA-approved. Head-to-head with semaglutide showing superior weight loss.
Tirzepatide week by week
The library places six of its research notes on tirzepatide on the days they cover, from day 1 to day 504 and on: 6 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | Getting your gut acclimated | Randomized trial |
| Days 29–56 (weeks 5–8) | First therapeutic dose — weight drops | Randomized trial |
| Days 57–112 (weeks 9–16) | Dual agonism in full effect | Randomized trial |
| Days 113–168 (weeks 17–24) | Max titration reached | Randomized trial |
| Days 169–504 (weeks 25–72) | Weeks 24 to 72: where most people plateau | Randomized trial |
| From day 365 on | A maintenance medication, not a course | Randomized trial |

Model. Individual results vary.
The tirzepatide timeline’s milestones
The library’s timeline for tirzepatide marks 10 points from week 1 to week 52, backed by clinical trial data overall.
- Week 1: Dual GIP/GLP-1 activation — appetite suppression often strong early
- Week 2: Commonly reported: meals ending early, with nausea or tiredness for a day or two after the injection
- Week 4: First escalation (5mg) — ~3–5% body weight loss
- Week 8: ~5–7% loss, metabolic improvements accelerating
- Week 12: ~6–9% loss; commonly reported: food noise quiet, meals ending early
- Week 16: Commonly reported: very strong appetite suppression
- Week 20: ~10–13% loss — insulin sensitivity notably improved
- Week 28: ~13–16% loss, cardiovascular markers improved
- Week 40: ~15–18% loss; many people are nearing their plateau
- Week 52: One year — on the way to the trial's 15–21% (by dose) at 72 weeks
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why tirzepatide takes that long
Tirzepatide’s half-life is about 5 days (120 hours), so one dose is about 96.9% cleared after 25 days.
On its schedule (Weekly) the doses overlap, and the level of tirzepatide keeps climbing for about 20–25 days before it levels off, so the first 20–25 days run below the level the later weeks hold.
The notes on tirzepatide follow the trials’ dose steps, 2.5mg, 5mg, 7.5mg and 12.5mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Tirzepatide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, tirzepatide among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does tirzepatide take to work?
Tirzepatide’s onset is days–2 weeks, its peak effect comes at 72+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does tirzepatide reach its peak effect?
By the library’s timeline, tirzepatide’s peak effect comes at 72+ weeks, backed by clinical trial data.
How long is tirzepatide usually run?
The library’s timeline gives tirzepatide’s typical duration as ongoing; its cycle note says: FDA-approved for ongoing use.
What does the library say about the first days on tirzepatide?
Its first note on tirzepatide, for days 1–28 (weeks 1–4), is “Getting your gut acclimated”, resting on randomized trials.